A developing method to gauge the occurrence of a nuclear reactor anomaly has the potential to save millions of dollars.
A team led by ORNL created a computational model of the proteins responsible for the transformation of mercury to toxic methylmercury, marking a step forward in understanding how the reaction occurs and how mercury cycles through the environment.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have a powerful new tool in the quest to produce better plants for biofuels, bioproducts and agriculture.
Oak Ridge National Laboratory scientists evaluating northern peatland responses to environmental change recorded extraordinary fine-root growth with increasing temperatures, indicating that this previously hidden belowground mechanism may play an important role in how carbon-rich peatlands respond to warming.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
Researchers at Oak Ridge National Laboratory developed a method that uses machine learning to predict seasonal fire risk in Africa, where half of the world’s wildfire-related carbon emissions originate.
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.